Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium sulphate + normal saline is a combination therapy being investigated for its anesthetic and analgesic effects in patients undergoing elective laparoscopic cholecystectomy. Magnesium sulphate functions as a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor and a blocker of voltage-gated calcium channels, mechanisms that contribute to its ability to modulate pain signaling and reduce the need for perioperative opioids. In this clinical trial setting, it is administered intravenously as a bolus followed by a continuous infusion, with normal saline (0.9% sodium chloride) serving as the diluent and vehicle. The study, led by Aretaieion University Hospital, aims to evaluate the impact of this regimen on recovery outcomes and postoperative pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium sulphate + normal saline.